These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16046513)

  • 1. Thalidomide for the nephrologist.
    Izzedine H; Launay-Vacher V; Deray G
    Nephrol Dial Transplant; 2005 Sep; 20(9):2011-2. PubMed ID: 16046513
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.
    Harris E; Behrens J; Samson D; Rahemtulla A; Russell NH; Byrne JL
    Br J Haematol; 2003 Jul; 122(1):160-1. PubMed ID: 12823359
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma.
    Lee CC; Wu YH; Chung SH; Chen WJ
    Oncologist; 2006 Jan; 11(1):87-8; author reply 89. PubMed ID: 16401719
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible paraparesis in multiple myeloma with renal failure.
    Terrier B; Joly D; Ghez D; Knebelmann B; Fakhouri F; Hummel A
    Nephrol Dial Transplant; 2006 May; 21(5):1439-40. PubMed ID: 16520348
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide and thrombosis.
    Mehta P
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide use and digital gangrene.
    Kang TY; Lowe CJ; Sekeres MA
    J Clin Oncol; 2006 Nov; 24(33):5328. PubMed ID: 17114666
    [No Abstract]   [Full Text] [Related]  

  • 7. Encephalopathy in a patient after long-term treatment with thalidomide.
    Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A
    J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide and bowel perforation: four cases in one hospital.
    McClay H; Cervi P
    Br J Haematol; 2008 Feb; 140(3):360-1. PubMed ID: 18042266
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
    Tamburini J; Elie C; Park S; Beyne-Rauzy O; Gardembas M; Berthou C; Mahe B; Sanhes L; Stamatoullas A; Vey N; Aouba A; Slama B; Quesnel B; Vekhoff A; Sotto JJ; Vassilief D; Al-Nawakil C; Fenaux P; Dreyfus F; Bouscary D;
    Leuk Res; 2009 Apr; 33(4):547-50. PubMed ID: 18640718
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
    Buttin BM; Moore MJ
    Gynecol Oncol; 2008 Dec; 111(3):546-8. PubMed ID: 18191185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
    Ballanti S; Mastrodicasa E; Bolli N; Lotti F; Capolsini I; Berchicci L; Merigiola C; Giordano G; Tabilio A
    Nat Clin Pract Oncol; 2007 Dec; 4(12):722-5. PubMed ID: 18037876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide-induced amenorrhea: case report and literature review.
    Dharia SP; Steinkampf MP; Cater C
    Fertil Steril; 2004 Aug; 82(2):460-2. PubMed ID: 15302302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thalidomide-associated bradycardia in patients with hematologic diseases: a single institution experience].
    López-de la Cruz I; Aguayo-González A; López-Karpovitch X
    Rev Invest Clin; 2006; 58(5):424-31. PubMed ID: 17408102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide and thrombosis. A meta-analysis.
    El Accaoui RN; Shamseddeen WA; Taher AT
    Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
    Pasa S; Altintas A; Cil T; Ustun C; Bayan K; Danis R; Urakci Z; Tuzun Y; Ayyildiz O
    Int J Infect Dis; 2009 Jan; 13(1):e19-22. PubMed ID: 18621563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
    Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
    Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.